Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-002930
Filing Date
2019-03-06
Accepted
2019-03-06 15:54:08
Documents
35
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 222292
2 ex5-1.htm EX-5.1 15978
3 ex31-1.htm EX-31.1 18966
4 ex31-2.htm EX-31.2 19533
5 ex32-1.htm EX-32.1 6560
6 ex32-2.htm EX-32.2 6689
  Complete submission text file 0001493152-19-002930.txt   1178351

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE prtt-20180630.xml EX-101.INS 93477
8 XBRL SCHEMA FILE prtt-20180630.xsd EX-101.SCH 15039
9 XBRL CALCULATION FILE prtt-20180630_cal.xml EX-101.CAL 22162
10 XBRL DEFINITION FILE prtt-20180630_def.xml EX-101.DEF 48198
11 XBRL LABEL FILE prtt-20180630_lab.xml EX-101.LAB 119717
12 XBRL PRESENTATION FILE prtt-20180630_pre.xml EX-101.PRE 88102
Mailing Address 4876 CECILE AVENUE LAS VEGAS NV 89115
Business Address 4876 CECILE AVENUE LAS VEGAS NV 89115 954-292-0033
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 19662450
SIC: 2834 Pharmaceutical Preparations